PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Vepesid 50mg capsules
0801040D0BBAAAA
Vepesid Etoposide Malignant Disease and Immunosuppression No data available
Versavo 100mg/4ml concentrate for inf vials
0801050APBHAAAA
Versavo Bevacizumab Malignant Disease and Immunosuppression No data available
Versavo 400mg/16ml concentrate for inf vials
0801050APBHABAB
Versavo Bevacizumab Malignant Disease and Immunosuppression No data available
Verzenios 100mg tablets
0801050CLBBAAAA
Verzenios Abemaciclib Malignant Disease and Immunosuppression No data available
Verzenios 150mg tablets
0801050CLBBABAB
Verzenios Abemaciclib Malignant Disease and Immunosuppression No data available
Verzenios 50mg tablets
0801050CLBBACAC
Verzenios Abemaciclib Malignant Disease and Immunosuppression No data available
Vesanoid 10mg capsules
0801050X0BBAAAA
Vesanoid Tretinoin Malignant Disease and Immunosuppression No data available
Vidaza 100mg powder for suspension for injection vials
0801030ACBBAAAA
Vidaza Azacitidine Malignant Disease and Immunosuppression No data available
Vinblastine 10mg powder for solution for injection vials
0801040H0AAAAAA
Vinblastine sulfate Vinblastine sulfate Malignant Disease and Immunosuppression No data available
Vinblastine 10mg/10ml solution for injection vials
0801040H0AAABAB
Vinblastine sulfate Vinblastine sulfate Malignant Disease and Immunosuppression No data available
Vincristine 1mg/1ml solution for injection vials
0801040M0AAAEAE
Vincristine sulfate Vincristine sulfate Malignant Disease and Immunosuppression No data available
Vincristine 2mg/2ml solution for injection vials
0801040M0AAAFAF
Vincristine sulfate Vincristine sulfate Malignant Disease and Immunosuppression No data available
Vincristine 5mg/5ml solution for injection vials
0801040M0AAAGAG
Vincristine sulfate Vincristine sulfate Malignant Disease and Immunosuppression No data available
Vindesine 5mg powder for solution for injection vials
0801040Q0AAAAAA
Vindesine sulfate Vindesine sulfate Malignant Disease and Immunosuppression No data available
Vinorelbine 10mg/1ml solution for infusion vials
0801040R0AAAAAA
Vinorelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Vinorelbine 20mg capsules
0801040R0AAACAC
Vinorelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Vinorelbine 30mg capsules
0801040R0AAADAD
Vinorelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Vinorelbine 50mg/5ml solution for infusion vials
0801040R0AAABAB
Vinorelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Vinorelbine 80mg capsules
0801040R0AAAEAE
Vinorelbine Vinorelbine Malignant Disease and Immunosuppression No data available
Viraferon 18million units/1.2ml inj multidose pens
0802040J0BFADBB
Viraferon Interferon alpha Malignant Disease and Immunosuppression No data available
Viraferon 18million units/3ml inj multidose vials
0802040J0BFACAU
Viraferon Interferon alpha Malignant Disease and Immunosuppression No data available
Viraferon 30million units/1.2ml inj multidose pens
0802040J0BFAEBC
Viraferon Interferon alpha Malignant Disease and Immunosuppression No data available
ViraferonPeg 100microgram inj pre-filled pens
0802040A0BBAIAK
ViraferonPeg Peginterferon alpha Malignant Disease and Immunosuppression No data available
ViraferonPeg 100microgram inj pre-filled pens CLEARCLICK
0802040A0BBAPAK
ViraferonPeg Peginterferon alpha Malignant Disease and Immunosuppression No data available
ViraferonPeg 100microgram inj vials
0802040A0BBABAB
ViraferonPeg Peginterferon alpha Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.